MAPK/ERK


The mitogen-activated protein kinase (MAPK) is a highly conserved family of serine/threonine kinases that mediate a board range of cellular processes, including proliferation, differentiation, motility, migration, stress response, apoptosis and survival. The activation of MAPK involves signaling pathways consisting of MAPK kinase (i.e. MAPKKK or MEKK) that activates MAPK/ERK (i.e. MAPKK or MEK). A variety of extracellular signals such as mitogens, cytokines, growth factors, and environmental stressors stimulate a phosphorylation-dependent increase in the activity of MAPK.
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
A3805 SCH7729847 CitationSummary: ERK1 and ERK2 inhibitor -
A3824 Skepinone-L2 CitationSummary: P38-MAPK inhibitor,potent and selective -
A3887 Trametinib DMSO solvate1 CitationTarget: MEKSummary: Allosteric MEK1/MEK2 kinase inhibitor -
A3931 VX-11e5 CitationTarget: ERKSummary: ERK inhibitor -
A3942 XMD17-109Target: ERKSummary: ERK-5 inhibitor -
A3943 XMD8-92Target: ERKSummary: BMK1/ERK5 inhibitor -
A4790 TBHQ -
A9925 p-Cresyl sulfate potassiumSummary: A potassium form of p-Cresyl sulfate that acts as a pro-inflammatory agent -
BA2003 U0126Summary: A potent, non-ATP-competitive, selective MEK inhibitor -
C8497 KRAS inhibitor-9

